Sadiq S T, McSorley J, Copas A J, Bennett J, Edwards S J, Kaye S, Kirk S, French P, Weller I V D
Centre for Sexual Health and HIV Research, Department of Primary Care and Population Sciences, Royal Free and University College Medical School, University College, London, UK.
Sex Transm Infect. 2005 Oct;81(5):380-5. doi: 10.1136/sti.2004.012914.
To examine the effect of early syphilis on blood and semen plasma HIV-1 viral loads and CD4 counts.
In a retrospective case-control study, blood plasma HIV-1 viral loads and CD4 counts in cases during early syphilis (n = 63, 27 receiving antiretroviral therapy) were compared to those before and after syphilis and with controls with non-systemic acute sexually transmitted infections (STI) (n = 104, 39 receiving antiretroviral therapy). In a prospective substudy in those not receiving antiretroviral therapy, semen plasma viral loads during early syphilis (n = 13) were compared with those 1 month, 3 months, and 6 months after treatment for syphilis and with controls with no STIs (n = 20).
Retrospective study: CD4 counts were similar in cases (median 410, n = 139 counts) during early syphilis compared to before (485, n = 80) and after (475, n = 88). In a secondary analysis, a drop in CD4 count (21%) among those with early latent syphilis was observed compared with controls. Blood plasma viral loads did not change significantly overall or in those with primary, secondary, or early latent syphilis. Effects were similar on or off antiretroviral therapy. Prospective study: blood and semen viral loads were slightly higher in cases compared with controls but treatment of early syphilis did not reduce either.
We detected no association between early syphilis and changes in blood or semen viral load or CD4 count. Increased HIV-1 infectivity associated with early syphilis is unlikely to be associated with increased levels of HIV-1 RNA in blood or semen.
研究早期梅毒对血液及精液中HIV-1病毒载量和CD4细胞计数的影响。
在一项回顾性病例对照研究中,将早期梅毒患者(n = 63,其中27例接受抗逆转录病毒治疗)血液中的HIV-1病毒载量和CD4细胞计数与梅毒发病前后的情况进行比较,并与非全身性急性性传播感染(STI)的对照组(n = 104,其中39例接受抗逆转录病毒治疗)进行比较。在一项针对未接受抗逆转录病毒治疗患者的前瞻性子研究中,将早期梅毒患者(n = 13)精液中的病毒载量与梅毒治疗后1个月、3个月和6个月时的情况进行比较,并与无STI的对照组(n = 20)进行比较。
回顾性研究:早期梅毒患者(中位数410,n = 139次计数)的CD4细胞计数与梅毒发病前(485,n = 80)及发病后(475,n = 88)相似。在二次分析中,观察到早期潜伏梅毒患者的CD4细胞计数较对照组下降了21%。血液中的病毒载量总体上没有显著变化,原发性、继发性或早期潜伏梅毒患者的病毒载量也无显著变化。无论是否接受抗逆转录病毒治疗,结果相似。前瞻性研究:与对照组相比,患者血液和精液中的病毒载量略高,但早期梅毒治疗并未使其降低。
我们未发现早期梅毒与血液或精液病毒载量变化或CD4细胞计数之间存在关联。早期梅毒相关的HIV-1传染性增加不太可能与血液或精液中HIV-1 RNA水平升高有关。